Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer

ANZ Journal of Surgery

Volumn 78, Issue 9, 2008, Pages 775-779

  Chan, Siew H ^a,b   Ng, Colin ^a   Looi, Lai M ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b HOSPITAL SUNGAI BULOH   (Malaysia)

Author keywords

Colorectal cancer; Methylene blue; Sentinel lymph node biopsy

Indexed keywords

CYTOKERATIN; ISOSULFAN BLUE; METHYLENE BLUE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLON RESECTION; COLON TUMOR; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; INTRAOPERATIVE PERIOD; LAPAROTOMY; LYMPH NODE METASTASIS; MALE; RECTUM RESECTION; RECTUM TUMOR; SENTINEL LYMPH NODE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; METHYLENE BLUE; MIDDLE AGED; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 50249156490     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2008.04648.x     Document Type: Article

References (45)

1. Lim GCC, Halimah Y (eds). Second Report of the National Cancer Registry, Cancer Incidence in Malaysia 2003. Kuala Lumpur, Malaysia : National Cancer Registry, Ministry of Health. 2004 Dec, www.crc.gov.my/ncr
2. Greene FL, American Joint Committee on Cancer; American Cancer Society. AJCC Cancer Staging Manual, 6th edn. New York : Springer-Verlag, 2002.
3. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg. 1954 139 : 846 52.
4. Benson AB 3rd., Schrag D, Somerfield MR et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J. Clin. Oncol. 2004 22 : 3408 19.
5. Cohen AM, Kelsen D, Saltz L et al. Adjuvant therapy for colorectal cancer. Curr. Probl. Surg. 1997 34 : 601 76.
6. Law CH, Wright FC, Rapanos T et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J. Surg. Oncol. 2003 84 : 120 26.
7. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am. J. Surg. Pathol. 2002 26 : 179 89.
8. Le Voyer TE, Sigurdson ER, Hanlon AL et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J. Clin. Oncol. 2003 21 : 2912 19.
9. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977 39 : 456 66.
10. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006 106 : 4 16.
11. Morton DL, Cochran AJ, Thompson JF et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann. Surg. 2005 242 : 302 11 discussion 11-13.
12. Kitagawa Y, Fujii H, Kumai K et al. Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J. Surg. Oncol. 2005 90 : 147 51 discussion 51-2.
13. Matsubara T, Ueda M, Kaisaki S et al. Localization of initial lymph node metastasis from carcinoma of the thoracic esophagus. Cancer 2000 89 : 1869 73.
14. Saha S, Wiese D, Badin J et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann. Surg. Oncol. 2000 7 : 120 24.
15. Wood TF, Nora DT, Morton DL et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J. Gastrointest. Surg. 2002 6 : 322 9 discussion 229-30.
16. Tuech JJ, Pessaux P, Di Fiore F et al. Sentinel node mapping in colon carcinoma: in-vivo versus ex-vivo approach. Eur. J. Surg. Oncol. 2006 32 : 158 61.
17. Longnecker SM, Guzzardo MM, Van Voris LP. Life-threatening anaphylaxis following subcutaneous administration of isosulfan blue 1%. Clin. Pharmacol. 1985 4 : 219 21.
18. Cimmino VM, Brown AC, Szocik JF et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001 130 : 439 42.
19. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology 2000 93 : 1145 6.
20. Albo D, Wayne JD, Hunt KK et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am. J. Surg. 2001 182 : 393 8.
21. Sprung J, Tully MJ, Ziser A. Anaphylactic reactions to isosulfan blue dye during sentinel node lymphadenectomy for breast cancer. Anesth. Analg. 2003 96 : 1051 3, table of contents.
22. Simmons R, Thevarajah S, Brennan MB, Christos P, Osborne M. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann. Surg. Oncol. 2003 10 : 242 7.
23. Blessing WD, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am. J. Surg. 2002 184 : 341 5.
24. Cutini G, Gesuelli GC, Sartelli M et al. The role of lymphoscintigraphy in rectal laparoscopic surgery: can the sentinel node concept be applied to rectal carcinoma? Surg. Endosc. 2001 15 : 1440 43.
25. TerwisschaVan Scheltinga SE, Den Boer FC, Pijpers R et al. Sentinel node staging in colon carcinoma: value of sentinel lymph node biopsy with radiocolloid and blue staining. Scand. J. Gastroenterol. Suppl. 2006 243 153 7.
26. Kitagawa Y, Watanabe M, Hasegawa H et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Dis. Colon Rectum 2002 45 : 1476 80.
27. British Medical Association; Royal Pharmaceutical Society of Great Britain. British National Formulary, London : British Medical Association, 2005.
28. Evora PR, Oliveira Neto AM, Duarte NM, Vicente WV. Methylene blue as treatment for contrast medium-induced anaphylaxis. J. Postgrad. Med. 2002 48 : 327.
29. Oliveira Neto AM, Duarte NM, Vicente WV, Viaro F, Evora PR. Methylene blue: an effective treatment for contrast medium-induced anaphylaxis. Med. Sci. Monit. 2003 9 : CS102 6.
30. Saha S, Seghal R, Patel M et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am. J. Surg. 2006 191 : 305 10.
31. Saha S, Dan AG, Beutler T et al. Sentinel lymph node mapping technique in colon cancer. Semin. Oncol. 2004 31 : 374 81.
32. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br. J. Surg. 1999 86 : 482 6.
33. Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mapping in patients with colon cancer. Ann. Surg. Oncol. 2002 9 : 550 54.
34. Bembenek A, Schneider U, Gretschel S, Fischer J, Schlag PM. Detection of lymph node micrometastases and isolated tumor cells in sentinel and nonsentinel lymph nodes of colon cancer patients. World J. Surg. 2005 29 : 1172 5.
35. Saha S, Monson KM, Bilchik A et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis. Colon Rectum 2004 47 : 1767 72.
36. Bell SW, Mourra N, Flejou JF, Parc R, Tiret E. Ex vivo sentinel lymph node mapping in colorectal cancer. Dis. Colon Rectum 2005 48 : 74 9.
37. Baton O, Lasser P, Sabourin JC et al. Ex vivo sentinel lymph node study for rectal adenocarcinoma: preliminary study. World J. Surg. 2005 29 : 1166 70, discussion 71.
38. Paramo JC, Summerall J, Wilson C et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am. J. Surg. 2001 182 : 40 43.
39. Dan AG, Saha S, Monson KM et al. 1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors. Arch. Surg. 2004 139 : 1180 84.
40. Read TE, Fleshman JW, Caushaj PF. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy. Dis. Colon Rectum 2005 48 : 80 85.
41. Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA. Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am. Surg. 2000 66 : 943 5 discussion 5-6.
42. Mulsow J, Winter DC, O'Keane JC, O'Connell PR. Sentinel lymph node mapping in colorectal cancer. Br. J. Surg. 2003 90 : 659 67.
43. Saha S, Nora D, Wong JH, Weise D. Sentinel lymph node mapping in colorectal cancer - a review. Surg. Clin. North Am. 2000 80 : 1811 19.
44. Saha S, Bilchik A, Wiese D et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. Ann. Surg. Oncol. 2001 8 9 Suppl 94S 8S.
45. Bertagnolli M, Miedema B, Redston M et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann. Surg. 2004 240 : 624 8 discussion 8-30.